Consun Pharmaceutical Group Ltd represents values of innovation, integrity, and excellence, as well as a strong commitment to quality healthcare. The company's corporate philosophy focuses on meeting the healthcare needs of individuals and communities by providing safe and effective pharmaceutical products. Consun Pharmaceutical Group Ltd emphasizes research and development, constantly striving to introduce new and improved treatments to enhance people's wellbeing. By maintaining the highest standards of ethical conduct and social responsibility, Consun Pharmaceutical Group Ltd has become a trusted name in the industry. With its dedication to delivering top-quality healthcare solutions, the company aims to improve the quality of life for patients worldwide.

Consun Pharmaceutical Group Ltd is primarily present in China, where it is based. As a leading pharmaceutical company, Consun focuses on research, development, manufacturing, and sales of innovative medicines and healthcare products. With a strong presence in the Chinese market, Consun has established a wide distribution network across various regions within China. The company's commitment to delivering high-quality healthcare solutions has contributed to its success and growth within the Chinese pharmaceutical industry.

Consun Pharmaceutical Group Ltd has achieved several significant milestones. The company successfully obtained Good Manufacturing Practice (GMP) certification, indicating its adherence to quality standards. It has also expanded its product portfolio and established strong market presence in both domestic and international markets. Consun Pharmaceutical Group Ltd has consistently reported steady revenue growth and secured strategic partnerships with leading pharmaceutical companies. Additionally, the company has invested in research and development, leading to the launch of innovative and high-quality pharmaceutical products. Through its commitment to excellence and continuous growth, Consun Pharmaceutical Group Ltd has positioned itself as a reputable player in the pharmaceutical industry.

Consun Pharmaceutical Group Ltd is a renowned pharmaceutical company with a rich history and background. Founded in 1983, the company has grown to become a leading provider of high-quality and innovative healthcare solutions. Consun Pharmaceutical Group Ltd has established itself as a trusted name in the industry, focusing on research, development, production, and marketing of traditional Chinese medicines, chemical drugs, biologics, and other pharmaceutical products. With a commitment to excellence, the company has achieved significant milestones in the field of pharmaceuticals, catering to the healthcare needs of people worldwide. Consun Pharmaceutical Group Ltd's dedication to innovation and quality makes it a reliable player in the global pharmaceutical market.

The main competitors of Consun Pharmaceutical Group Ltd in the market include Pfizer Inc., Johnson & Johnson, Novartis AG, and Roche Holding AG.

Consun Pharmaceutical Group Ltd is primarily active in the pharmaceutical industry. With a focus on research, development, manufacturing, and marketing of pharmaceutical products, Consun Pharmaceutical Group Ltd operates within the healthcare sector. This Chinese company specializes in producing and distributing both modern Western medicines and traditional Chinese medicines. Consun Pharmaceutical Group Ltd aims to provide high-quality and affordable healthcare solutions to the global market.

Consun Pharmaceutical Group Ltd is a leading pharmaceutical company, specializing in the research, development, production, and sale of modern Chinese medicines. The core of their business model lies in integrating traditional Chinese medicine with advanced pharmaceutical technologies. Consun Pharmaceutical Group Ltd focuses on the production and distribution of prescription drugs, over-the-counter drugs, and healthcare products. By leveraging their strong research and development capabilities, they strive to deliver high-quality pharmaceutical products that cater to the healthcare needs of individuals. With a customer-centric approach, Consun Pharmaceutical Group Ltd continues to enhance their product offerings while maintaining their commitment to improving the overall well-being of the community.

P/E odnos Consun Pharmaceutical Group iznosi 6,29.

KUV kompanije Consun Pharmaceutical Group iznosi 1,91.

AlleAktien kvalitativni skor za Consun Pharmaceutical Group je 10/10.

očekivana Consun Pharmaceutical Group promet je 2,98 milijardi CNY.

Dobit očekivana Consun Pharmaceutical Group je 901,94 mil. CNY.

The Consun Pharmaceutical Group Ltd is a Chinese company specializing in the manufacturing and sale of pharmaceutical products, as well as the development of medical technologies. The company operates in three main divisions: Pharmaceuticals, Medical Devices, and Health Services. The Pharmaceuticals division includes the production and sale of pharmaceutical products, including prescription drugs, over-the-counter medications, and health products. The company produces a wide range of medicines, including drugs for the treatment of cardiovascular diseases, diabetes, cancer, infectious diseases, and other conditions. Additionally, Consun also offers alternative medicine products based on oriental healing methods and natural ingredients. The second division, Medical Devices, produces and sells medical equipment and devices such as ultrasound machines, X-ray machines, CT scanners, and other medical instruments. The company has a strong presence in the Chinese market and is striving for further international expansion. Finally, Consun offers health services, including health and wellness programs, medical examinations and diagnostics, hospital administration, and pharmaceutical research and development. There is a network of health centers and clinics throughout China that provide consultations, examinations, and treatments. In terms of research and development, Consun is constantly working to develop innovative technologies and therapies, particularly in the field of cancer drugs and personalized medicine. The company has a strong and growing presence in the international research and development sector and actively collaborates with various institutions and universities. In summary, Consun Pharmaceutical Group Ltd offers a wide range of products and services in the healthcare field, including pharmaceutical products, medical devices, and health services. The company has a strong presence in the Chinese market and is striving for further international expansion. Finally, Consun aims to be innovative and develop new technologies and therapies.

Consun Pharmaceutical Group isplaćuje dividendu od 0,20 CNY raspoređenu preko isplata u toku godine.

Dividenda za Consun Pharmaceutical Group trenutno ne može biti izračunata ili kompanija ne isplaćuje dividendu.

ISIN od Consun Pharmaceutical Group je KYG2524A1031.

WKN od Consun Pharmaceutical Group je A1XAEC.

Oznaka za praćenje akcija kompanije Consun Pharmaceutical Group je 1681.HK.

U poslednjih 12 meseci, Consun Pharmaceutical Group je isplatio dividendu u iznosu od 0,45 CNY . To odgovara dividendnom prinosu od oko 6,33 %. Za narednih 12 meseci, Consun Pharmaceutical Group će verovatno isplatiti dividendu od 0,52 CNY.

Dividendski prinos od Consun Pharmaceutical Group trenutno iznosi 6,33 %.

Consun Pharmaceutical Group isplaćuje dividende na kvartalnom nivou. One se isplaćuju u mesecima јул, октобар, јул, октобар.

Consun Pharmaceutical Group je isplaćivao dividendu svake godine u poslednjih 13 godina.

Za narednih 12 meseci očekuju se dividende u iznosu od 0,52 CNY. To odgovara dividendnom prinosu od 7,32 %.

Consun Pharmaceutical Group se svrstava u sektor 'Zdravlje'.

Da biste primili poslednju dividendu od Consun Pharmaceutical Group od 20. 9. 2024. u iznosu od 0,3 CNY, morali ste da imate akciju u depou pre Ex-dana 5. 9. 2024..

Isplata poslednje dividende izvršena je 20. 9. 2024..

U godini 2023 kompanija Consun Pharmaceutical Group je isplatila 0,2 CNY kao dividende.

Dividende od Consun Pharmaceutical Group se isplaćuju u CNY.